Technology

Core capabilities and development pipeline

Below is our technical foundation and where each program currently stands. Some detail is withheld until patents publish; for substantive partnership discussions we can share more under NDA.

Core capabilities

Three capabilities that reinforce each other

Porous-material fluid control

Porous UHMWPE acts as the distribution medium; output behaviour is designed through pore size distribution and differential pressure characteristics. We run our own incoming inspection and statistical process control on the material rather than relying on supplier datasheets alone.

Mean flow pore size: 6.45 μm
Inspection sample: n = 30
Pressure drop CV: ≈ 6.2 %
Method: Differential pressure

Figures are internal inspection statistics used to set control limits, not product specifications.

Closed-loop gas circuit

A diaphragm-pump driven closed circuit holds a stable circulating flow at low pressure, with separate filtration on the clean and contaminated sides. Connectors follow the ISO 22 mm respiratory circuit standard so we can draw on a mature supply chain.

Circuit flow: 14 LPM
System pressure: < 0.5 bar
Connector: ISO 22 mm
Clean-side filter: BFE ≥ 99.999 %

Microstructure forming & drying

Vacuum casting into porous molds, paired with a directional drying process and a dedicated applicator. This is the core of our second product line; the structures and process parameters are currently at patent application stage.

Forming: Vacuum cast
Mold material: Porous polyolefin
IP status: Pending

Structural detail withheld until publication.

Image slotPorous wall / nozzle sample, close up — on a caliper or graph paper so scale readsSuggested size · 1600 × 900 px

Image slotMicroneedle mold or patch sample — overall appearance only, avoid unpublished structural detailSuggested size · 1600 × 900 px

Pipeline

Where each program stands

In development

Laparoscopic spray delivery system

An instrument delivery system for gynecological minimally invasive surgery. A closed-loop gas circuit drives liquid through a porous wall to produce distributed output. The system itself contains no drug or medical-grade gel; the gel used with it is a separately approved third-party product, and the instrument IFU stays brand-neutral.

Registration follows a split strategy: the reusable pump unit and the single-use sterile consumable set are filed separately, an approach with existing precedent both in Taiwan and abroad.

Concept　→　Prototype　→　Design verification　→　Validation　→　Registration　→　Launch

StageDesign verification

RegulatoryTFDA pre-submission classification inquiry

IPTW invention I931290 + utility model (nozzle)

SpecialtyGynecological MIS

Early stage

Dissolving microneedle patch platform

A bilayer microstructured patch on a water-soluble polymer matrix, with a dedicated mold and vacuum applicator. The platform is designed so the active formulation can be adapted to a partner's requirements. Indication direction is still under evaluation and not yet fixed.

The regulatory plan follows the medical device route with no drug claims. A product attribute determination inquiry has been submitted to the authority.

Concept　→　Prototype & formulation　→　Verification　→　Validation　→　Registration　→　Launch

StagePrototype & formulation

RegulatoryTFDA attribute determination inquiry

IPPatents pending (equipment, mold, applicator)

ProgramSBIR Phase 1 in application

Regulatory notice

All products described on this page are under development and have not received medical device approval from the Taiwan Food and Drug Administration. This page describes technical development progress for the purpose of partnership discussion. It does not constitute medical device advertising and makes no claim as to efficacy, safety, or clinical outcome. Final specifications, indications, and timelines will follow the terms of approval once granted.